Houlihan Lokey Advises Fingerpaint (3)

Houlihan Lokey is pleased to announce that Fingerpaint, a full-service health and wellness marketing firm with a global team of more than 580 people, has acquired Splice, a healthcare communications business based in Emeryville, California. The transaction closed on June 11, 2021.

Fingerpaint is known for its innovative and data-driven approach to providing analytics-enabled, integrated marketing solutions to a growing roster of healthcare clients, specifically in the pharmaceutical, rare disease, and gene therapy sectors. The acquisition and full integration of Splice into the Fingerpaint brand will bolster the company—which was just named Agency of the Year, Category I, by Med Ad News—give it a footprint on the West Coast, and support its continued commitment to being a best-in-class commercialization services provider for biopharma.

Formed in 2019 and based in San Francisco, Knox Lane is a middle-market investment firm led by and composed of a team of accomplished investors and operators with a shared work history and a strong track record of partnering with leading companies to accelerate transformational growth. Knox Lane employs an investor-operator mindset and seeks to provide support across a number of business components, including human capital, brand management, end-to-end digital transformation, sourcing, supply chain and logistics, strategic acquisitions, and business development. Knox Lane is a strategic investor in Fingerpaint.

As part of the transaction, Splice Co-Founder Paul Hagopian will continue to lead the group’s day-to-day operations, reporting directly to McEllen. Hagopian has nearly 25 years of healthcare communications expertise and held a number of leadership positions prior to founding Splice.

Houlihan Lokey acted as financial advisor to Fingerpaint.